China Signals Restarting IPOs For Unprofitable Biotechs

 
• By Dexter Jie Yan
  
Going public
New “growth tier” proposed for Shanghai STAR Market for listing standards for unprofitable firms. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from China